| Original language | English |
|---|---|
| Pages (from-to) | 1089-1093 |
| Number of pages | 5 |
| Journal | Pharmacogenomics |
| Volume | 19 |
| Issue number | 14 |
| DOIs | |
| State | Published - 2018 |
Funding
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
ASJC Scopus Subject Areas
- Molecular Medicine
- Genetics
- Pharmacology
Keywords
- carvedilol
- CYP2D6
- drug interactions
- enantiomer
- heart failure
- P-glycoprotein
- pharmacokinetics
- polymorphism
- stereo-selective metabolism
- β-blocker
Disciplines
- Medical Molecular Biology
- Genetics
- Pharmacology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS